Search Results - "Costello, J. González"

Cancer Incidence in Heart Transplant Recipients With Previous Neoplasia History by Delgado, J. F., Alonso‐Pulpón, L., Mirabet, S., Almenar, L., Villa, F. P., González‐Vílchez, F., Palomo, J., Blasco, T., Dolores García‐Cosio, M., González‐Costello, J., Fuente, L., Rábago, G., Lage, E., Pascual, D., Molina, B. D., Arizón, J. M., Muñiz, J., Crespo‐Leiro, M. G.

“…Neoplasm history increases morbidity and mortality after solid organ transplantation and has disqualified patients from transplantation. Studies are needed to…”
Get full text

Donor‐transmitted malaria after heart transplant managed successfully with artesunate by Sabé, N., González‐Costello, J., Oriol, I., Sánchez‐Salado, J.C., Ortega, S., Oliver, E., Manito, N., Carratalà, J.

“…Donor‐transmitted malaria is a rare complication in solid organ transplantation, which causes high mortality. Data concerning the use of artesunate in solid…”
Get full text

Successful outcome of ganciclovir-resistant cytomegalovirus infection in organ transplant recipients after conversion to mTOR inhibitors by Sabé, N, González-Costello, J, Rama, I, Niubó, J, Bodro, M, Roca, J, Cruzado, J M, Manito, N, Carratalà, J

“…Ganciclovir-resistant (GanR) cytomegalovirus (CMV) infection after organ transplantation is emerging as a significant therapeutic challenge. We report two…”
Get more information

The Impact of Culturing the Organ Preservation Fluid on Solid Organ Transplantation: A Prospective Multicenter Cohort Study by Oriol, I, Sabe, N, Càmara, J, Berbel, D, Ballesteros, M A, Escudero, R, Lopez-Medrano, F, Linares, L, Len, O, Silva, J T, Oliver, E, Soldevila, L, Pérez-Recio, S, Guillem, L L, Camprubí, D, LLadó, L, Manonelles, A, González-Costello, J, Domínguez, M A, Fariñas, M C, Lavid, N, González-Rico, C, Garcia-Cuello, L, Arnaiz de las Revillas, F, Fortun, J, Aguado, J M, Jimenez-Romero, C, Bodro, M, Almela, M, Paredes, D, Moreno, A, Pérez-Cameo, C, Muñoz-Sanz, A, Blanco-Fernández, G, Cabo-González, J A, García-López, J L, Nuño, E, Carratalà, J

“…Abstract Background We analyzed the prevalence, etiology, and risk factors of culture-positive preservation fluid and their impact on the management of solid…”
Get full text

Neurohormonal activation induces intracellular iron deficiency and mitochondrial dysfunction in cardiac cells by Tajes, M, Díez-López, C, Enjuanes, C, Moliner, P, Ferreiro, J L, Garay, A, Jiménez-Marrero, S, Yun, S, Sosa, S G, Alcoberro, L, González-Costello, J, García-Romero, E, Yañez-Bisbe, L, Benito, B, Comín-Colet, J

“…Iron deficiency (ID) is common in patients with heart failure (HF) and is associated with poor outcomes, yet its role in the pathophysiology of HF is not…”
Get full text

Factors influencing mortality in solid organ transplant recipients with bloodstream infection by Oriol, I., Sabé, N., Melilli, E., Lladó, L., González-Costello, J., Soldevila, L., Carratalà, J.

“…Although bloodstream infection (BSI) is a major cause of mortality after solid organ transplantation, information regarding its prognostic factors is scarce…”
Get full text

Clinical Features and Outcomes of Tuberculosis in Solid Organ Transplant Recipients by Bodro, M, Sabé, N, Santín, M, Cruzado, J.M, Lladó, L, González-Costello, J, Carratalà, J

“…Abstract Background Tuberculosis (TB) remains a significant opportunistic infection in solid organ transplant (SOT) recipients. Moreover, its optimal treatment…”
Get full text

Impact of mobilization in patients with short-term mechanical circulatory support such as Levitronix® CentriMag as a bridge to heart transplantation by Chicano-Corrales, A., Bañeras-Rius, J., de Frutos, F., Sánchez-Salado, J.C., Ariza-Solé, A., Blasco-Lucas, A., Sbraga, F., Díez-López, C., Calvo-Barriuso, E., Castillo García, J., Molina-Mazón, C.S., López-López, A., Tinoco-Amorós, I., Abellán-García, A., González-Costello, J.

“…Despite the benefits of mobilisation in the critical patient, the evidence in patients with Levitronix® CentriMag as a bridge to heart transplantation (HT) is…”
Get full text

Safety of the Use of Prothtombin Complex in Anticoagulated Patients Before Heart Transplantation by González-Costello, J, Couto, D, Domènech, P, Muntané, G, Ortega, S, Roca, J, Salazar-Mendiguchía, J, Miralles, A, Sbraga, F, Cequier, A, Manito, N

Get full text

Neoplasia after Heart Transplantation. Differences in Incidence and Prognosis between Genders. Data from the Spanish Post-Heart Transplant Tumor Registry by Crespo-Leiro, M.G, Segovia Cubero, J, Delgado-Jiménez, J.F, Roig-Minguell, E, Barge-Caballero, E, Sousa-Casasnovas, I, Almenar-Bonet, L, González-Vilchez, F, González-Costello, J, Díaz-Molina, B, Sobrino-Márquez, J.M, Rábago, G, Arizón del Prado, J.M, Pérez-Villa, F, Blasco Peiró, T, de la Fuente-Galán, L, Garrido Bravo, I.P, Muñiz, J

Get full text

Renal Function Improvement After Conversion to Proliferation Signal Inhibitors During Long-Term Follow-up in Heart Transplant Recipients by Kaplinsky, E, González-Costello, J, Manito, N, Roca, J, Barbosa, M.J, Nebot, M, Salazar-Mendiguchia, J, Berdejo, J, Mañas, P, Miralles, A, Cequier, A

“…Abstract Introduction The use of proliferation signal inhibitors (PSIs) for calcineurin-inhibitor (CNI) minimization or conversion protocols has been promoted…”
Get full text

650 High Rate of Discontinuation of a Mammalian Target of Rapamycin Inhibitor Based Regime during Long-Term Follow-Up of Cardiac Transplant Recipients by González-Costello, J, Kaplinsky, E, Manito, N, Roca, J, Nebot, M, Barbosa, M.J, Mañas, P, Salazar, J, Miralles, A, Cequier, A

Get full text

247 Peak Exercise Capacity in Continuous-Flow Left Ventricular Assist Device Recipients May Be Determined by Right Ventricular Performance by González-Costello, J, Uriel, N, Murray, L, Shames, S, Kozco, A, Sims, D.B, Morrison, K, Colombo, P.C, Takayama, H, Naka, Y, Gillam, L, Jorde, U.P

Get full text

Curva de aprendizaje y pronóstico en pacientes con shock cardiogénico refractario tratados con soporte ventricular tipo ECMO by Ariza-Solé, A, Sánchez-Salado, J.C, Lorente, V, González-Costello, J, Sbraga, F, Cequier, Á

Get full text

Current heart failure disease management and treatment in accredited units from cardiology and internal medicine in Spain by Santiago-Vacas, E., Anguita, M., Casado, J., F. García-Prieto, C., González-Costello, J., Matalí, A., González-Franco, Á., Trueba-Sáiz, Á., Manzano, L.

“…Heart failure (HF) is a complex disease with high prevalence, incidence and mortality rates leading to high healthcare burden. In Spain, there are…”
Get full text

Learning curve and prognosis in patients with refractory cardiogenic shock receiving ECMO ventricular support by Ariza-Solé, A, Sánchez-Salado, J C, Lorente, V, González-Costello, J, Sbraga, F, Cequier, Á

Get more information

Preliminary Results of a Randomized Clinical Trial of Intravenous Immunoglobulin in Solid Organ Recipients with Severe Infection and Secondary Antibody Deficiency by Carbone, J., Montanchez, J., Cifrian, J., Laporta, R., Ussetti, P., Zatarain, E., Sousa, I., Muñoz, P., Ezzahouri, I., Salcedo, M., Rodriguez-Ferrero, M., Bravo, C., Segovia, J., Gomez-Bueno, M., Fernandez-Sabe, N., Gonzalez-Costello, J., De Pablos, A., Sarmiento, E.

“…Infection is a cause of death in solid organ transplantation. Secondary antibody deficiency is a risk factor of severe infection in solid organ…”
Get full text

Role of Everolimus in Providing Protection from CMV Infection after Transplant by Improving T-cell Specific Immunity by García-Romero, E., Díez-López, C., Olivella, A., Roca, J., Bestard, O., Sabé, N., Manito, N., González-Costello, J.

“…Prevention of Citomegalovirus (CMV) infection in heart transplant is currently based on humoral immune status, and mismatch recipients (R-/D+) are the higher…”
Get full text

Hypophosphatemia After Intravenous Ferric Carboxymaltose in Heart Transplant Patients by Santulario-Verdú, L., Echeverry-Navarrete, E., Díez-López, C., Canedo-Castelo, M., Juvany-Roig, R., García-Romero, E., Roca-Elías, J., Manito-Lorite, N., González-Costello, J.

“…Iron deficiency and iron deficiency anemia are both comorbidities potentially occurring in patients with heart failure (HF) and in patients undergoing heart…”
Get full text

Impact of Treatment with m-TOR Inhibitors on Platelet Reactivity in Heart Transplant Patients Treated with Clopidogrel. Preliminary Results by Gonzalez-Costello, J, Ferreiro, J, Roca, J, Marcano, A, Rodríguez, I, Salazar-Mendiguchia, J, Tatjer, I, Miralles, A, Manito, N, Cequier, A

Get full text